• Info
  • Insider Ownership

Insider Trading & Ownership of FOREST BASKETT

Location
Menlo Park, CA
Summary
The estimated net worth of FOREST BASKETT is at least $395M dollars as of 06 Oct 2025. FOREST BASKETT is the 10%+ Owner of Monte Rosa Therapeutics, Inc. and owns shares of Monte Rosa Therapeutics, Inc. (GLUE) stock worth about $146M. FOREST BASKETT is the 10%+ Owner of Savara Inc and owns shares of Savara Inc (SVRA) stock worth about $109M. FOREST BASKETT is the 10%+ Owner of Korro Bio, Inc. and owns shares of Korro Bio, Inc. (KRRO) stock worth about $61.1M. FOREST BASKETT is the 10%+ Owner of MBX Biosciences, Inc. and owns shares of MBX Biosciences, Inc. (MBX) stock worth about $38.6M. FOREST BASKETT is the 10%+ Owner of Trevi Therapeutics, Inc. and owns shares of Trevi Therapeutics, Inc. (TRVI) stock worth about $21.1M. FOREST BASKETT is the 10%+ Owner of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $15M. FOREST BASKETT is the 10%+ Owner of Coursera, Inc. and owns shares of Coursera, Inc. (COUR) stock worth about $1.85M. FOREST BASKETT is the 10%+ Owner of Metacrine, Inc. and owns shares of Metacrine, Inc. stock worth about $1.2M. FOREST BASKETT is the Director of Robinhood Markets, Inc. and owns shares of Robinhood Markets, Inc. (HOOD) stock worth about $451K. FOREST BASKETT is the 10%+ Owner of IonQ, Inc. and owns shares of IonQ, Inc. (IONQ) stock worth about $126K. FOREST BASKETT is the 10%+ Owner of AVEO PHARMACEUTICALS, INC. and owns shares of AVEO PHARMACEUTICALS, INC. stock worth about $48.3K. FOREST BASKETT is the 10%+ Owner of Sagimet Biosciences Inc. and owns shares of Sagimet Biosciences Inc. (SGMT) stock worth about $46.3K. FOREST BASKETT is the 10%+ Owner of Mirum Pharmaceuticals, Inc. and owns shares of Mirum Pharmaceuticals, Inc. (MIRM) stock worth about $43.4K. FOREST BASKETT is the 10%+ Owner of Desktop Metal, Inc. and owns shares of Desktop Metal, Inc. (DM) stock worth about $5.38K. FOREST BASKETT is the 10%+ Owner of Eargo, Inc. and owns shares of Eargo, Inc. stock worth about $4.22K.
Signature
/s/ Zachary Bambach, attorney-in-fact
All Insider Reports
All Insider Reports

Notify me when FOREST BASKETT files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of FOREST BASKETT

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GLUE Monte Rosa Therapeutics, Inc. 10%+ Owner $146M 28 Jun 2021
SVRA Savara Inc 10%+ Owner $109M 17 Jul 2023
KRRO Korro Bio, Inc. 10%+ Owner $61.1M 22 Apr 2024
MBX MBX Biosciences, Inc. 10%+ Owner $38.6M 16 Sep 2024
TRVI Trevi Therapeutics, Inc. 10%+ Owner $21.1M 11 Apr 2022
ARDX ARDELYX, INC. 10%+ Owner $15M 09 Dec 2021
COUR Coursera, Inc. 10%+ Owner $1.85M 15 Feb 2023
MTCR Metacrine, Inc. 10%+ Owner $1.2M 10 Dec 2021
HOOD Robinhood Markets, Inc. Director $451K 02 May 2022
IONQ, IONQ-WT IonQ, Inc. 10%+ Owner $126K 16 Nov 2022
AVEO AVEO PHARMACEUTICALS, INC. 10%+ Owner $48.3K 19 Oct 2022
SGMT Sagimet Biosciences Inc. 10%+ Owner $46.3K 29 Jan 2024
MIRM Mirum Pharmaceuticals, Inc. 10%+ Owner $43.4K 13 Jun 2023
DM Desktop Metal, Inc. 10%+ Owner $5.38K 08 Jun 2021
EAR Eargo, Inc. 10%+ Owner $4.22K 24 May 2021
NEUE NeueHealth, Inc. Director, 10%+ Owner $0 -$5.67K -100% 02 Oct 2025
AKUS Akouos, Inc. 10%+ Owner 30 Nov 2022
ACLX Arcellx, Inc. 10%+ Owner 20 Dec 2022
GNCA GENOCEA BIOSCIENCES, INC. 10%+ Owner 24 May 2022

Insider Transactions Reported by FOREST BASKETT:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.